Access Bio Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 79

Employees

  • Stock Symbol
  • 950130

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $1.21
  • (As of Tuesday Closing)

Access Bio General Information

Description

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 7 Fitzgerald Avenue
  • Monroe Township, NJ 08831
  • United States
+1 (732)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Medical Supplies
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 7 Fitzgerald Avenue
  • Monroe Township, NJ 08831
  • United States
+1 (732)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Access Bio Stock Performance

As of 17-Nov-2026, Access Bio’s stock price is $1.21. Its current market cap is $42.5M with 35.2M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.21 $1.23 $1.20 - $3.18 $42.5M 35.2M 124K -$2.17

Access Bio Financials Summary

As of 30-Jun-2026, Access Bio has a trailing 12-month revenue of $16.2M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV (162,689) (151,061) (77,538) (33,458)
Revenue 16,219 21,962 82,424 266,659
EBITDA (94,467) (69,410) 6,458 (490)
Net Income (76,425) (57,702) (255) (2,427)
Total Assets 409,138 422,178 502,964 536,314
Total Debt 47,462 29,753 44,807 56,757
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Access Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Access Bio‘s full profile, request access.

Request a free trial

Access Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro
Diagnostic Equipment
Monroe Township, NJ
79 As of 2025

Hercules, CA
 

Wicklow, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Access Bio Competitors (7)

One of Access Bio’s 7 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bio-Rad Laboratories Corporation Hercules, CA
Trinity Biotech Corporation Wicklow, Ireland
altona Diagnostics Corporation Hamburg, Germany
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
Orasure Technologies Corporate Backed or Acquired Bethlehem, PA
You’re viewing 5 of 7 competitors. Get the full list »

Access Bio Patents

Access Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250116668-A1 Multiplexed diagnostic assay device Pending 25-Aug-2023
WO-2025049225-A2 Multiplexed diagnostic assay device Inactive 25-Aug-2023
WO-2025049225-A3 Multiplexed diagnostic assay device Inactive 25-Aug-2023
US-12055544-B2 Diagnostic assay device having microreactor Active 25-Aug-2022
US-12613242-B2 Diagnostic assay device having microreactor Active 25-Aug-2022 G01N33/54391
To view Access Bio’s complete patent history, request access »

Access Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Access Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Access Bio‘s full profile, request access.

Request a free trial

Access Bio Investments & Acquisitions (5)

Access Bio’s most recent deal was a Merger/Acquisition with RF Bio for . The deal was made on 19-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
RF Bio 19-Jan-2026 Merger/Acquisition Biotechnology
AACG 07-Jan-2026 Joint Venture Clinics/Outpatient Services
CuraPatient 12-Sep-2023 Corporate Clinics/Outpatient Services
Beright Investment 26-May-2023 Merger/Acquisition Consulting Services (B2B)
Genecast 23-Feb-2023 Later Stage VC Diagnostic Equipment
To view Access Bio’s complete investments and acquisitions history, request access »

Access Bio Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
RF Bio Wonju-si, South Korea 2020

Access Bio FAQs

  • When was Access Bio founded?

    Access Bio was founded in 2002.

  • Where is Access Bio headquartered?

    Access Bio is headquartered in Monroe Township, NJ.

  • What is the size of Access Bio?

    Access Bio has 79 total employees.

  • What industry is Access Bio in?

    Access Bio’s primary industry is Diagnostic Equipment.

  • Is Access Bio a private or public company?

    Access Bio is a Public company.

  • What is Access Bio’s stock symbol?

    The ticker symbol for Access Bio is 950130.

  • What is the current stock price of Access Bio?

    As of 17-Nov-2026 the stock price of Access Bio is $1.21.

  • What is the current market cap of Access Bio?

    The current market capitalization of Access Bio is $42.5M.

  • What is Access Bio’s current revenue?

    The trailing twelve month revenue for Access Bio is $16.2M.

  • Who are Access Bio’s competitors?

    Bio-Rad Laboratories, Trinity Biotech, altona Diagnostics, Charles River Laboratories International, and Orasure Technologies are some of the 7 competitors of Access Bio.

  • What is Access Bio’s annual earnings per share (EPS)?

    Access Bio’s EPS for 12 months was -$2.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process